HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 15,580
-670 (-4.12%)
At close: Feb 6, 2026
-39.61% (1Y)
| Market Cap | 218.78B -38.8% |
| Revenue (ttm) | 36.10B +75.7% |
| Net Income | 472.66M |
| EPS | 34.13 |
| Shares Out | 14.04M |
| PE Ratio | 462.87 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 125,523 |
| Average Volume | 310,338 |
| Open | 15,920 |
| Previous Close | 16,250 |
| Day's Range | 15,000 - 16,000 |
| 52-Week Range | 12,500 - 33,250 |
| Beta | 0.48 |
| RSI | 40.75 |
| Earnings Date | Mar 20, 2026 |